Live Chat

I CFD sono strumenti complessi e presentano un alto rischio di perdere soldi rapidamente a causa della leva finanziaria. Il 76,3% dei conti di clienti al dettaglio perde denaro facendo trading con i CFD con questo fornitore. Devi verificare se comprendi pienamente come funzionano i CFD e se puoi permetterti di correre il rischio elevato di perdere i tuoi soldi.

Close

Fai trading su AbbVie ABBV

Grafico live di AbbVie

Percezioni e opinioni

Weekly Search
Weekly
Daily
date Chiudi change variazione % Apertura Massimo Minimo

Markets.com news

French election results to drive European markets
markets.com Support Team 2024 Jul 04, 21:00

La prossima settimana: I risultati delle elezioni francesi saranno chiave per i mercati europei

Forex Indici
Macron calls snap election, riles markets
markets.com Support Team 2024 Jun 29, 21:00

La prossima settimana: La Francia scatenerà una crisi dell'euro?

CPI
Businessman pointing hologram online banking icon.
markets.com Support Team 2024 Jun 20, 16:00

La prossima settimana: Una carrellata di dati e uno sguardo all’inflazione

Forex Indici
RBA, SNB, Bank of England rate decisions due next week
markets.com Support Team 2024 Jun 13, 21:00

La prossima settimana: RBA e Bank of England - status quo o cambio all’orizzonte?

Forex Indici

Informazioni

Spread

1.07

Spread (%)

0.6252 %

Leva

1:5

Interesse overnight acquisto

-0.0597 %

Interesse overnight vendita

-0.0292 %

Valuta

USD

Orari di trading

Markets closed

Martedì

14:31 - 20:59

Lunedì

14:31-20:59

Mercoledì

14:31-20:59

Giovedi

14:31-20:59

Venerdì

14:31-20:59

Conto economico

Apertura

---

Chiusura precedente

---

Massimo/Minimo di 52 settimane

--- – ---

Capitalizzazione di mercato

315240087552

Azioni in circolazione

1767139968

Data delle trimestrali (prossima)

0000-00-00

instr__dividend_date

2025-02-14

instr__ex_dividend_date

2025-01-15

instr__forward_annual_dividend_rate

6.56

instr__forward_annual_dividend_yield

0.0374

EPS

2.87

Azioni in circolazione

AbbVie AbbVie Inc
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; Evolveimmune Therapeutics, Inc.; Genentech, Inc.; and Tentarix Biotherapeutics, LP. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Scopri di più su questo strumento

Strumenti correlati
Trustpilot
Live Chat